News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Arndt Vogel: Neratinib alone has no effect, but are the combinations promising?
Arndt Vogel/X
Apr 3, 2025, 09:59

Arndt Vogel: Neratinib alone has no effect, but are the combinations promising?

Arndt Vogel, Director of the Center for Personalized Medicine at Hannover Medical School, shared a post on X about recent paper by Ghassan K. Abou-Alfa et al.:

“Neratinib Alone or in Combination with Immune Checkpoint Inhibitors with or without mTOR Inhibitors in Fibrolamellar Carcinoma Liver Cancer

Not sure what to conclude… Neratinib alone has no effect, but are the combinations promising?”

Authors: Ghassan K. Abou-Alfa et al.

Arndt Vogel

Albert S. Cornelius Alison Clemens O'Neill Amin Yaqubie Arndt Vogel cancer Crystal S. Denlinger Daniel DiPrimeo David B. Solit Eileen M. O'Reilly fibrolamellar carcinoma Ghassan K. Abou-Alfa James J. Harding John D. Gordan Joseph S. Light Lisa D. Eli liver cancer OncoDaily Oncology Pablo Cano Raed Al-Rajabi Richard Kinh Gian Do Sarina A Piha-Paul Scott Sherrin Tim Meyer
Special Coverage
Blog
Apr 3, 2025, 09:59
Arndt Vogel: Neratinib alone has no effect, but are the combinations promising?
Blog
Apr 3, 2025, 09:56
Rajesh Sharma: My abstract got accepted for a poster presentation at the ASCO2025
Blog
Apr 3, 2025, 09:48
Mark Lythgoe: Great to be editors pick in The Lancet Oncology this month
Blog
Apr 3, 2025, 09:44
Colin Stirling: Flinders HealthCARE Centre – a game changer for our community
Blog
Apr 3, 2025, 09:43
Should NTCP models take the lead in radiation oncology treatment decisions? - ESTRO
Career
Apr 3, 2025, 09:39
Melvin Chua: Honoured to be Nominated as the Commissioner of the ICRU
Science
Apr 3, 2025, 09:29
Yan Leyfman: Ammonia - A Hidden Obstacle in Cancer Immunotherapy
Drugs
Apr 3, 2025, 09:27
Hidehito Horinouchi: Real-World Outcomes of Tarlatamab in SCLC
Blog
Apr 3, 2025, 09:16
Wafaa M Rashed: Submit your abstract for AORTIC 2025
Career
Apr 3, 2025, 09:14
Sarbajit Mukherjee: Thrilled to join Miami Cancer Institute as Chief of GI Medical Oncology
Science
Apr 3, 2025, 09:13
Myeloma Paper of the Day, April 3rd, suggested by Robert Orlowski
Insight
Apr 3, 2025, 09:04
Rami Manochakian: Honored to receive the 2025 Mayo Clinic Teacher Of The Year Award